Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 357

The DOI matches its Crossref record; 426 of the 426 references it cites were found in a registry or an index.

Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia

Open access
Han, Fengxuan, Wang, Jiayuan, Ding, Luguang, Hu, Yuanbin, Li, Wenquan, Yuan, Zhangqin, Guo, Qianping, Zhu, Caihong, Yu, Li, Wang, Huan, Zhao, Zhongliang, Jia, Luanluan, Li, Jiaying, Yu, Yingkang, Zhang, Weidong, Chu, Genglei, Chen, Song, Li, Bin·2020·Frontiers in Bioengineering and Biotechnology

Abstract

Exploring innovative solutions to improve the healthcare of the aging and diseased population continues to be a global challenge. Among a number of strategies toward this goal, tissue engineering and regenerative medicine (TERM) has gradually evolved into a promising approach to meet future needs of patients. TERM has recently received increasing attention in Asia, as evidenced by the markedly increased number of researchers, publications, clinical trials, and translational products. This review aims to give a brief overview of TERM development in Asia over the last decade by highlighting some of the important advances in this field and featuring major achievements of representative research groups. The development of novel biomaterials and enabling technologies, identification of new cell sources, and applications of TERM in various tissues are briefly introduced. Finally, the achievement of TERM in Asia, including important publications, representative discoveries, clinical trials, and examples of commercial products will be introduced. Discussion on current limitations and future directions in this hot topic will also be provided.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fbioe.2020.00083

Cites

426 of 426 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 426 references

Cited by

See all 357

Metadata

Authors
Han, F., Wang, J., Ding, L., Hu, Y., Li, W., Yuan, Z., Guo, Q., Zhu, C., Yu, L., Wang, H., Zhao, Z., Jia, L., Li, J., Yu, Y., Zhang, W., Chu, G., Chen, S., & Li, B.
Venue
Frontiers in Bioengineering and Biotechnology
Published
2020-03-24
Volume
8
Pages
83-83
ISSN
2296-4185 (ISSN-L)
OpenAlex
W3013938759
Cited by
357
References
426
FWCI
29.98
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia. https://app.cochat.ai/papers/10.3389/fbioe.2020.00083
The paper
Han, F., Wang, J., Ding, L., Hu, Y., Li, W., Yuan, Z., Guo, Q., Zhu, C., Yu, L., Wang, H., Zhao, Z., Jia, L., Li, J., Yu, Y., Zhang, W., Chu, G., Chen, S., & Li, B. (2020). Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia. Frontiers in Bioengineering and Biotechnology. https://doi.org/10.3389/fbioe.2020.00083

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.